Two Sigma Advisers
ALIM

Two Sigma Advisers’s Alimera Sciences ALIM Stock Holding History

Two Sigma Advisers’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,320
Closed -$110K – 2465
2014
Q4 		$110K Buy
+1,320
New +$107K ﹤0.01% 2316

Other funds holding ALIM

SM
Scale Management Foster City, California $359M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Two Sigma Advisers's ALIM Position: Q1 2015 in Review

Two Sigma Advisers sold out of Alimera Sciences (ALIM) in Q1 2015, closing a stake of 1,320 shares — an estimated $110K sold.

Two Sigma Advisers first reported a position in ALIM in Q4 2014 and held it in 1 quarter. The position peaked at $110K in Q4 2014. 64 funds tracked by Wall St. Rank hold ALIM as of Q1 2015.

  • Two Sigma Advisers reported no remaining Alimera Sciences position as of Q1 2015 after selling out during the quarter.
  • Two Sigma Advisers sold 1,320 Alimera Sciences shares in Q1 2015, an estimated $110K.
  • Two Sigma Advisers first reported a position in Alimera Sciences in Q4 2014 and held it in 1 quarter.
  • Two Sigma Advisers's Alimera Sciences position peaked at $110K in Q4 2014.
  • 64 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2015.

Based on Two Sigma Advisers's 13F filing for Q1 2015, filed 15 May 2015.